Key facts pulled from the official settlement site; not yet independently field-verified — confirm details on the official site.
Revance Therapeutics Merger Securities Settlement
Settle claims in the $17M Revance Therapeutics merger securities settlement if you purchased stock or notes during the disputed period.
$17,000,000 total settlement fund; individual payout amounts cannot be determined at this time and depend on valid claims submitted and allocation formula
Who may qualify
You are eligible if you purchased or acquired Revance Therapeutics common stock or convertible notes anytime between February 29, 2024 and February 6, 2025 (when Crown Laboratories completed its acquisition of Revance).
You qualify if you purchased or acquired Revance Therapeutics common stock (ticker RVNC) or 1.75% fixed coupon convertible senior unsecured notes during February 29, 2024 through February 6, 2025 (close of Crown Laboratories merger)
This summary is based on available official settlement sources. The settlement administrator determines eligibility and payment approval.
Important dates
- Claim deadline
- August 28, 2026
- Exclusion deadline
- July 13, 2026
- Objection deadline
- July 13, 2026
Proof requirements
Proof requirement is currently marked as Yes.
Review the official claim form before submitting any information.
What you need
File a Proof of Claim and Release Form by August 28, 2026 with supporting documentation of your purchase or acquisition of Revance securities (brokerage statements or transaction records required to verify ownership and dates)
How do I file a claim for this settlement?
File directly with A.B. Data, Ltd., P.O. Box 173120, Milwaukee, WI 53217; (877) 507-1390; info@RevanceSecuritiesSettlement.com via the official claim form before August 28, 2026.
- Confirm you are within the eligible group described in the official notice — the settlement administrator determines eligibility.
- Gather any documents the official form asks for — this settlement marks proof as Yes.
- Open the official claim form or settlement website run by A.B. Data, Ltd., P.O. Box 173120, Milwaukee, WI 53217; (877) 507-1390; info@RevanceSecuritiesSettlement.com.
- Submit accurate information through the official settlement administrator or government source before August 28, 2026.
- Save your confirmation number if one is provided, then watch the payment status for distribution updates.
New to settlement claims? How to file safely →
Worried it might be fake? Run the 60-second legitimacy check →
How we verified this record
- Claim deadline queued for re-check
- Payout details queued for re-check
- Eligibility queued for re-check
- Proof requirement queued for re-check
- Administrator queued for re-check
- Official claim link queued for re-check
- Court case queued for re-check
- Payment status queued for re-check
Every published record clears our source-verification bar; remaining fields are checked one by one on our weekly re-verification pass.
Checked fields are matched against a named official source and re-checked on a schedule. We show the authority and the date, never our internal evidence link.
Common questions
Who may qualify for this settlement?
You qualify if you purchased or acquired Revance Therapeutics common stock (ticker RVNC) or 1.75% fixed coupon convertible senior unsecured notes during February 29, 2024 through February 6, 2025 (close of Crown Laboratories merger)
What is the claim deadline?
The claim deadline is August 28, 2026. Confirm the current deadline on the official settlement source before filing.
Do I need proof to claim?
Proof requirement: Yes. The settlement administrator determines what documentation, if any, is required.
What is the current payment status?
Current payment status: Unknown. Payments are issued by the administrator after the court process concludes.
When will Revance Therapeutics Merger Securities Settlement pay out?
Current payment status: Unknown. Class-action payouts typically begin only after final approval and any appeals. See our payout timeline guide.
Where is the official Revance Therapeutics Merger Securities Settlement claim form?
The official claim form is hosted by the settlement administrator, A.B. Data, Ltd., P.O. Box 173120, Milwaukee, WI 53217; (877) 507-1390; info@RevanceSecuritiesSettlement.com. Use the 'Open official claim form' button on this page — never pay a fee to file.
Who are the defendants in this settlement?
Revance Therapeutics, Inc., Mark J. Foley (former executive), and Tobin C. Schilke. The company was acquired by Crown Laboratories, Inc. on February 6, 2025.
What were the allegations in this case?
Plaintiffs alleged that defendants made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the merger transaction with Crown Laboratories. Defendants deny these allegations.
When must I file my claim?
Your claim must be postmarked or filed online by August 28, 2026. Exclusion and objection requests must be received by July 13, 2026.
What documentation do I need to submit?
You must submit a completed Proof of Claim and Release Form with documentation proving your purchase or acquisition of Revance securities during the class period (February 29, 2024 - February 6, 2025), such as brokerage statements or trade confirmations.
How much will I receive?
Individual payments cannot be determined until all valid claims are received. Payments depend on the total number of claims filed and each claimant's share of losses. The $17 million will be divided among eligible class members.
Where to act
When you are ready, you open the official claim form yourself. SettleSignal does not file claims or determine eligibility.
Use the official settlement administrator or government source.
Listed on the official settlement website (A.B. Data).
Disclaimer
This service summarizes publicly available settlement information and links to official settlement sources. We are not a law firm, do not provide legal advice, do not submit claims on your behalf, and do not determine eligibility or payout approval. Only file a claim if the information you provide is accurate.
Change log
- June 9, 2026 — Settlement published after verification.